Direkt zum Inhalt

Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men

There is good evidence that nonoxynol-9 does not protect against sexually transmitted infections (STI), and there is some evidence that it may be harmful by increasing the rate of genital ulceration. As such, this product cannot be recommended for STI prevention.

Hintergrund

The incidence and prevalence of sexually transmitted infections (STI) and other reproductive tract infections (RTI) is high in much of the developing and parts of the developed worlds. STIs and RTIs are associated with the vaginal transmission of HIV. Additional strategies to improve STI control are needed, and vaginal microbicides are a possible strategy. One potential vaginal microbicide is the widely used spermicide, nonoxynol-9 (N-9).

Zielsetzungen

To determine the safety and effectiveness of N-9 in preventing vaginal acquisition of sexual transmitted infections (exclusive of HIV) by women from men.

Suchstrategie

Systematic search of electronic databases, conference abstracts, reference lists of relevant studies and contact with experts and funders.

Auswahlkriterien

Randomised controlled trials meeting pre-determined quality criteria with STI as the outcome.

Datensammlung und ‐analyse

Data were extracted by one reviewer and checked by another.

Hauptergebnisse

Ten of 12 identified randomised controlled trials were included and findings among them were broadly consistent. In meta-analysis, the risks of gonorrhoea (relative risk [RR] 0.91, 95%CI 0.67-1.24), cervical infection (RR 1.01, 0.84-1.22), trichomoniasis (RR 0.84, 0.69-1.02), bacterial vaginosis (0.88, 0.74-1.04), chlamydia (RR 0.88, 0.77-1.01) and candidiasis (RR 0.97, 0.84-1.12) were not statistically significantly different in women receiving N-9 compared with placebo. Genital lesions were more common in the N-9 users (RR 1.17, 95%CI 1.02-1.35).

Schlussfolgerungen der Autoren

There is good evidence that nonoxynol-9 does not protect against sexually transmitted infections, and there is some evidence that it may be harmful by increasing the rate of genital ulceration. As such, this product cannot be recommended for STI prevention.

Zitierung
Wilkinson D, Ramjee G, Tholandi M, Rutherford GW. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD003939. DOI: 10.1002/14651858.CD003939.

So verwenden wir Cookies

Wir verwenden notwendige Cookies, damit unsere Webseite funktioniert. Wir möchten auch optionale Cookies für Google Analytics setzen, um unsere Webseite zu verbessern. Solche optionalen Cookies setzen wir nur, wenn Sie dies zulassen. Wenn Sie dieses Programm aufrufen, wird ein Cookie auf Ihrem Gerät platziert, um Ihre Präferenzen zu speichern. Sie können Ihre Cookie-Einstellungen jederzeit ändern, indem Sie auf den Link "Cookie-Einstellungen" am Ende jeder Seite klicken.
Auf unserer Seite zu Cookies finden Sie weitere Informationen, wie diese Cookies funktionieren die Seite mit den Cookies.

Alle akzeptieren
Anpassen